Our findings are also in agreement with reports concerning upregulation of SNHG1 in other neurological disorders such as in vitro cell models of Parkinson’s disease (PD) [29] and Alzheimer’s disease (AD) [59], a mouse model of PD [29], and human postmortem brain tissue samples derived from PD patients [28]. Here, SNHG1 is linked to early-onset autosomal dominant Alzheimer disease.